无机材料学报 ›› 2026, Vol. 41 ›› Issue (7): 983-992.DOI: 10.15541/jim20250433
收稿日期:2025-10-30
修回日期:2025-11-24
出版日期:2026-07-20
网络出版日期:2026-01-21
通讯作者:
吴 桐, 教授. E-mail: tongwu24@163.com作者简介:徐 铭(1998-), 男, 博士研究生. E-mail: xumingmed@163.com
基金资助:
XU Ming1,2(
), WANG Yuanfei3, WU Tong1,2(
)
Received:2025-10-30
Revised:2025-11-24
Published:2026-07-20
Online:2026-01-21
Contact:
WU Tong, professor. E-mail: tongwu24@163.comAbout author:XU Ming (1998-), male, PhD candidate. E-mail: xumingmed@163.com
Supported by:摘要:
由创伤、感染或骨质疏松引起的骨缺损是临床重大挑战, 开发能够有效促进骨再生的生物活性材料尤为重要。本研究通过溶胶-凝胶法制备了介孔生物活性玻璃(MBG), 并通过物理吸附法构建了负载葛根素(Pue)的Pue/MBG复合材料。结果显示, 制备的MBG具有较大比表面积和有序介孔结构, 成功实现了Pue的负载和缓释。体外实验结果表明, Pue/MBG复合材料能有效促进小鼠胚胎前成骨细胞和大鼠骨髓间充质干细胞的增殖, 同时增强其成骨分化能力, 具体表现为早期碱性磷酸酶活性的提高和晚期矿化结节形成的增强。综上, 本研究成功制备了一种基于Pue与MBG协同作用的高效骨修复复合材料, 其良好的成骨能力在骨组织工程中具有良好的应用前景。
中图分类号:
徐铭, 王元非, 吴桐. 葛根素/介孔生物活性玻璃复合材料的制备及体外协同促成骨作用研究[J]. 无机材料学报, 2026, 41(7): 983-992.
XU Ming, WANG Yuanfei, WU Tong. Preparation and in vitro Synergistic Osteogenic-promoting Effect of Puerarin/Mesoporous Bioactive Glass Composites[J]. Journal of Inorganic Materials, 2026, 41(7): 983-992.
图2 MBG和Pue/MBG的表面形貌和粒径分析
Fig. 2 Surface morphology and particle size analysis of MBG and Pue/MBG (a, b) Digital photos of (a) MBG and (b) Pue/MBG; (c, d) SEM images of (c) MBG and (d) Pue/MBG; (e, f) TEM images of (e) MBG and (f) Pue/MBG; (g, h) Particle size distribution diagrams of (g) MBG and (h) Pue/MBG
图3 MBG和Pue/MBG的(a) N2吸附-脱附等温线以及(b)对应的孔径分布
Fig. 3 (a) N2 adsorption-desorption isotherms and (b) corresponding pore size distributions of MBG and Pue/MBG
| Sample | BET surface area/(m2·g−1) | Pore volume/ (cm3·g−1) | BJH pore size/nm |
|---|---|---|---|
| MBG | 373.28 | 0.70 | 12.93 |
| Pue/MBG | 151.02 | 0.45 | 8.84 |
表1 MBG和Pue/MBG的比表面积与介孔分析
Table 1 Specific surface area and mesoporous analysis of MBG and Pue/MBG
| Sample | BET surface area/(m2·g−1) | Pore volume/ (cm3·g−1) | BJH pore size/nm |
|---|---|---|---|
| MBG | 373.28 | 0.70 | 12.93 |
| Pue/MBG | 151.02 | 0.45 | 8.84 |
图4 MBG和Pue/MBG的XRD谱图
Fig. 4 XRD patterns of MBG and Pue/MBG (a) Wide-angle XRD pattern of MBG; (b) Small-angle XRD patterns of MBG and Pue/MBG; (c) Enlarged view of rectangular region in Fig. (b)
| Sample | DLC/μg | DLR/% | EE/% |
|---|---|---|---|
| Pue/MBG | 338.38±16.05 | 33.84±1.61 | 9.02±0.43 |
表2 Pue/MBG的载药量、载药率和包封率
Table 2 Drug loading capacity, drug loading rate, and encapsulation efficiency of Pue/MBG
| Sample | DLC/μg | DLR/% | EE/% |
|---|---|---|---|
| Pue/MBG | 338.38±16.05 | 33.84±1.61 | 9.02±0.43 |
图8 Pue/MBG的体外生物相容性评估
Fig. 8 In vitro biocompatibility evaluation of Pue/MBG (a, c) Cell viability assay of (a) MC3T3-E1 and (c) rBMSCs; (b, d) Cell morphology staining of (b) MC3T3-E1 and (d) rBMSCs. Colorful figures are available on website
图9 Pue/MBG的成骨分化作用
Fig. 9 Osteogenic differentiation effects of Pue/MBG (a) ALP activity assay and (b) ALP staining images on 7 days; (c) ARS quantitative analysis and (d) ARS staining images on 14 days. Colorful figures are available on website
| [1] | WEI Y, PAN H, YANG J, et al. Aligned cryogel fibers incorporated 3D printed scaffold effectively facilitates bone regeneration by enhancing cell recruitment and function. Science Advances, 2024, 10(6): eadk6722. |
| [2] |
YU C, CHEN J, WANG T, et al. GelMA hydrogels reinforced by PCL@GelMA nanofibers and bioactive glass induce bone regeneration in critical size cranial defects. Journal of Nanobiotechnology, 2024, 22(1): 696.
DOI PMID |
| [3] |
MOY P K, AGHALOO T. Risk factors in bone augmentation procedures. Periodontology 2000, 2019, 81(1): 76.
DOI PMID |
| [4] |
LALZAWMLIANA V, ANAND A, ROY M, et al. Mesoporous bioactive glasses for bone healing and biomolecules delivery. Materials Science and Engineering: C, 2020, 106: 110180.
DOI URL |
| [5] |
VALLET-REGI M, SALINAS A J. Mesoporous bioactive glasses for regenerative medicine. Materials Today Bio, 2021, 11: 100121.
DOI URL |
| [6] |
SCHUMACHER M, HABIBOVIC P, VAN RIJT S. Mesoporous bioactive glass composition effects on degradation and bioactivity. Bioactive Materials, 2021, 6(7): 1921.
DOI PMID |
| [7] |
CUI Y, HONG S, JIANG W, et al. Engineering mesoporous bioactive glasses for emerging stimuli-responsive drug delivery and theranostic applications. Bioactive Materials, 2024, 34: 436.
DOI PMID |
| [8] |
ZHOU Y X, ZHANG H, PENG C. Puerarin: a review of pharmacological effects. Phytotherapy Research, 2014, 28(7): 961.
DOI URL |
| [9] |
ZENG X, FENG Q, ZHAO F, et al. Puerarin inhibits TRPM3/miR-204 to promote MC3T3-E1 cells proliferation, differentiation and mineralization. Phytotherapy Research, 2018, 32(6): 996.
DOI PMID |
| [10] |
YANG X, YANG Y, ZHOU S, et al. Puerarin stimulates osteogenic differentiation and bone formation through the ERK1/2 and p38-MAPK signaling pathways. Current Molecular Medicine, 2018, 17(7): 488.
DOI PMID |
| [11] |
YANG Y, CHEN D, LI Y, et al. Effect of puerarin on osteogenic differentiation in vitro and on new bone formation in vivo. Drug Design, Development and Therapy, 2022, 16: 2885.
DOI URL |
| [12] |
KANG S, BENNETT C N, GERIN I, et al. Wnt signaling stimulates osteoblastogenesis of mesenchymal precursors by suppressing CCAAT/enhancer-binding protein alpha and peroxisome proliferator-activated receptor gamma. Journal of Biological Chemistry, 2007, 282(19): 14515.
DOI PMID |
| [13] |
LI B, WANG Y, GONG S, et al. Puerarin improves OVX-induced osteoporosis by regulating phospholipid metabolism and biosynthesis of unsaturated fatty acids based on serum metabolomics. Phytomedicine, 2022, 102: 154198.
DOI URL |
| [14] |
PANG Z, WEI Y, WANG N, et al. Gel formation of puerarin and mechanistic study during its cooling process. International Journal of Pharmaceutics, 2018, 548(1): 625.
DOI PMID |
| [15] |
ZHANG L. Pharmacokinetics and drug delivery systems for puerarin, a bioactive flavone from traditional Chinese medicine. Drug Delivery, 2019, 26(1): 860.
DOI PMID |
| [16] |
HU Q, LI Y, ZHAO N, et al. Facile synthesis of hollow mesoporous bioactive glass sub-micron spheres with a tunable cavity size. Materials Letters, 2014, 134: 130.
DOI URL |
| [17] |
YUN H S, KIM S H, LEE S, et al. Synthesis of high surface area mesoporous bioactive glass nanospheres. Materials Letters, 2010, 64(16): 1850.
DOI URL |
| [18] |
HENCH L L, WILSON J. Surface-active biomaterials. Science, 1984, 226(4675): 630.
PMID |
| [19] |
YANG S Y, HU Y, ZHAO R, et al. Quercetin-loaded mesoporous nano-delivery system remodels osteoimmune microenvironment to regenerate alveolar bone in periodontitis via the miR-21a-5p/ PDCD4/NF-κB pathway. Journal of Nanobiotechnology, 2024, 22(1): 94.
DOI |
| [20] |
ZHENG K, BOCCACCINI A R. Sol-Gel processing of bioactive glass nanoparticles: a review. Advances in Colloid and Interface Science, 2017, 249: 363.
DOI PMID |
| [21] |
LIGA S, VODĂ R, LUPA L, et al. Synthesis of Ag2O/Ag nanoparticles using puerarin: characterization, cytotoxicity, in ovo safety profile, antioxidant, and antimicrobial potential against nosocomial pathogens. Journal of Functional Biomaterials, 2025, 16(7): 258.
DOI URL |
| [22] |
GARCÍA-PERDIGUERO J C, GÓMEZ-CEREZO N, GISBERT- GARZARÁN M, et al. Unraveling the role of calcium in the osteogenic behavior of mesoporous bioactive glass nanoparticles. Acta Biomaterialia, 2025, 198: 482.
DOI URL |
| [23] | CHEN M, WANG Y, YUAN P, et al. Multifunctional bioactive glass nanoparticles: surface-interface decoration and biomedical applications. Regenerative Biomaterials, 2024, 11: rbae110. |
| [24] |
WANG X, WANG G, ZHANG Y. Research on the biological activity and doxorubicin release behavior in vitro of mesoporous bioactive SiO2-CaO-P2O5 glass nanospheres. Applied Surface Science, 2017, 419: 531.
DOI URL |
| [25] |
ANAND A, DAS P, NANDI S K, et al. Development of antibiotic loaded mesoporous bioactive glass and its drug release kinetics. Ceramics International, 2020, 46(4): 5477.
DOI URL |
| [26] |
SOUNDRAPANDIAN C, MAHATO A, KUNDU B, et al. Development and effect of different bioactive silicate glass scaffolds: in vitro evaluation for use as a bone drug delivery system. Journal of the Mechanical Behavior of Biomedical Materials, 2014, 40: 1.
DOI URL |
| [27] |
ZHU Y, KASKEL S. Comparison of the in vitro bioactivity and drug release property of mesoporous bioactive glasses (MBGs) and bioactive glasses (BGs) scaffolds. Microporous and Mesoporous Materials, 2009, 118(1): 176.
DOI URL |
| [28] |
ZHAO L, YAN X, ZHOU X, et al. Mesoporous bioactive glasses for controlled drug release. Microporous and Mesoporous Materials, 2008, 109(1): 210.
DOI URL |
| [29] |
ALMASRI D, DAHMAN Y. Impact of composition and surfactant-templating on mesoporous bioactive glasses structural evolution, bioactivity, and drug delivery property. Journal of Biomaterials Applications, 2025, 39(9): 1064.
DOI URL |
| [30] |
VIMALRAJ S. Alkaline phosphatase: structure, expression and its function in bone mineralization. Gene, 2020, 754: 144855.
DOI URL |
| [31] |
QUARLES L D, YOHAY D A, LEVER L W, et al. Distinct proliferative and differentiated stages of murine MC3T3-E1 cells in culture: an in vitro model of osteoblast development. Journal of Bone and Mineral Research, 1992, 7(6): 683.
DOI URL |
| [32] |
BROWN E M, MACLEOD R J. Extracellular calcium sensing and extracellular calcium signaling. Physiological Reviews, 2001, 81(1): 239.
DOI PMID |
| [33] |
LIU Y K, LU Q Z, PEI R, et al. The effect of extracellular calcium and inorganic phosphate on the growth and osteogenic differentiation of mesenchymal stem cells in vitro: implication for bone tissue engineering. Biomedical Materials, 2009, 4(2): 025004.
DOI URL |
| [34] |
DANOUX C B, BASSETT D C, OTHMAN Z, et al. Elucidating the individual effects of calcium and phosphate ions on hMSCs by using composite materials. Acta Biomaterialia, 2015, 17: 1.
DOI PMID |
| [1] | 张博, 付一敏, 陈政, 石澳, 朱敏. 近红外光响应的双相抗菌介孔生物活性玻璃复合支架的制备及抗菌性能研究[J]. 无机材料学报, 2025, 40(10): 1137-1144. |
| [2] | 张淑敏, 奚晓雯, 孙磊, 孙平, 王德强, 魏杰. 基于声动力和类酶活性的铌基涂层: 抗菌及促进细胞增殖与分化[J]. 无机材料学报, 2024, 39(10): 1125-1134. |
| [3] | 谢家晔, 李力文, 朱强. 三种临床盖髓剂的抗菌性及生物相容性对比研究[J]. 无机材料学报, 2023, 38(12): 1449-1456. |
| [4] | 郭小炜, 李玉妍, 陈南春, 王秀丽, 解庆林. 负载二甲酸钾缓释抗菌微球的构建[J]. 无机材料学报, 2021, 36(2): 181-187. |
| [5] | 胡丽芳,刘柳,何杰,孙志鹏,陈小平. Ni-Ti-LDHs纳米片对阿司匹林的负载与缓释[J]. 无机材料学报, 2020, 35(2): 165-172. |
| [6] | 李昆强,乔玉琴,刘宣勇. 钛表面铜离子注入对细菌和细胞行为的影响[J]. 无机材料学报, 2020, 35(2): 158-164. |
| [7] | 黄长兴, 崔骏, 裴元生. B2O3-SiO2-Na2O缓释材料的合成工艺参数优化及其缓释机理[J]. 无机材料学报, 2019, 34(6): 653-659. |
| [8] | 白家峰, 王希庆, 陈义昌, 邓勇辉, 李志华, 刘 鸿, 刘绍华. 聚多巴胺修饰的介孔二氧化硅微球的合成及其用于负载左旋薄荷醇凉味剂[J]. 无机材料学报, 2017, 32(8): 845-850. |
| [9] | 余素春, 喻 莹, 戴红莲. 明胶微球/磷酸镁基骨水泥复合药物缓释体系的构建[J]. 无机材料学报, 2017, 32(6): 655-660. |
| [10] | 史蕊蕊, 李 萌, 裴元生. B2O3-SiO2-Na2O缓释抑菌剂的合成及性能表征[J]. 无机材料学报, 2017, 32(5): 529-534. |
| [11] | 鲍 艳, 王 彤. 中空SiO2微球的制备及其在缓/控释应用中的新进展[J]. 无机材料学报, 2016, 31(12): 1269-1278. |
| [12] | 董志红, 聂志萍, 周长春. 自然唾液中介孔生物活性玻璃诱导牙釉质仿生再矿化研究[J]. 无机材料学报, 2016, 31(1): 88-94. |
| [13] | 朱开平, 王德平, 范宏圆, 王 会, 姚爱华, 叶 松. 硼酸盐玻璃的原位转化及对浸泡液酸碱度的影响[J]. 无机材料学报, 2015, 30(10): 1069-1074. |
| [14] | 李彦云, 李松梅, 刘建华, 于 美. TPN-十二烷基磺酸钠-层状双金属氢氧化物纳米杂化物的制备及防霉性能研究[J]. 无机材料学报, 2014, 29(5): 515-522. |
| [15] | 张译轩, 李松梅, 刘建华, 于 美. BIT-层状双金属氢氧化物纳米杂化物的制备及防霉性能研究[J]. 无机材料学报, 2013, 28(9): 1025-1032. |
| 阅读次数 | ||||||
|
全文 |
|
|||||
|
摘要 |
|
|||||